✦ LIBER ✦

Therapeutic nuclear medicine expands to breast cancer

✍ Scribed by Marc André Mahé; Albert Lisbona; Jean-François Chatal

Publisher: Springer
Year: 2009
Tongue: English
Weight: 62 KB
Volume: 37
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-009-1319-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

From theatomonof Democritus to the thera

From theatomonof Democritus to the therapeutic nuclear medicine of today

✍ Georgios Spyridonos Limouris 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 420 KB

Sentinel node biopsy: role of nuclear me

Sentinel node biopsy: role of nuclear medicine in conservative surgery of breast cancer

✍ Giovanni Paganelli 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 14 KB

Diagnostic and therapeutic analysis to 5

Diagnostic and therapeutic analysis to 5 cases of male breast cancer

✍ Li Jiang; Xinbo Xue; Xiaoping Chen 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 135 KB

Nerve growth factor/nuclear factor-κB pa

Nerve growth factor/nuclear factor-κB pathway as a therapeutic target in breast cancer

✍ Ali Naderi; Luke Hughes-Davies 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 516 KB

Relationship of nuclear appearance to st

Relationship of nuclear appearance to stromal invasion in human breast cancer

✍ Dr. C. D. Bell; J. Stadler; M. Michowitz; M. Inbar 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Osteoblastic metastatic disease as a the

Osteoblastic metastatic disease as a therapeutic response to adjuvant chemotherapy in breast cancer

✍ Angela L. Demartini; Aman U. Buzdar; George R. Blumenschein 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Included in this study were 43 breast cancer patients treated with adjuvant chemotherapy who presented metastasis only in bone. Forty-two percent had metastasis during chemotherapy, and 58% had metastasis after the completion of chemotherapy. In 66% of the patients, the lesions were osteolytic. Twen